Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Relay Therapeutics (RLAY) Preferred Shares (2019)

Relay Therapeutics has reported Preferred Shares over the past 1 years, most recently at $537.8 million for Q4 2019.

  • Quarterly Preferred Shares changed N/A to $537.8 million in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $537.8 million through Dec 2019, changed N/A year-over-year, with the annual reading at $537.8 million for FY2019, N/A changed from the prior year.
  • Preferred Shares was $537.8 million for Q4 2019 at Relay Therapeutics.
  • Over five years, Preferred Shares peaked at $537.8 million in Q4 2019 and troughed at $537.8 million in Q4 2019.